Cargando…

Synergistic immunotoxin-paclitaxel combination against lymphoma

Detalles Bibliográficos
Autor principal: Müller, Fabian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5509450/
https://www.ncbi.nlm.nih.gov/pubmed/28637932
http://dx.doi.org/10.18632/aging.101251
_version_ 1783250021290868736
author Müller, Fabian
author_facet Müller, Fabian
author_sort Müller, Fabian
collection PubMed
description
format Online
Article
Text
id pubmed-5509450
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-55094502017-08-03 Synergistic immunotoxin-paclitaxel combination against lymphoma Müller, Fabian Aging (Albany NY) Editorial Impact Journals LLC 2017-06-13 /pmc/articles/PMC5509450/ /pubmed/28637932 http://dx.doi.org/10.18632/aging.101251 Text en Copyright: © 2017 Müller http://creativecommons.org/licenses/by/3.0/ This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) (CC-BY), which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Editorial
Müller, Fabian
Synergistic immunotoxin-paclitaxel combination against lymphoma
title Synergistic immunotoxin-paclitaxel combination against lymphoma
title_full Synergistic immunotoxin-paclitaxel combination against lymphoma
title_fullStr Synergistic immunotoxin-paclitaxel combination against lymphoma
title_full_unstemmed Synergistic immunotoxin-paclitaxel combination against lymphoma
title_short Synergistic immunotoxin-paclitaxel combination against lymphoma
title_sort synergistic immunotoxin-paclitaxel combination against lymphoma
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5509450/
https://www.ncbi.nlm.nih.gov/pubmed/28637932
http://dx.doi.org/10.18632/aging.101251
work_keys_str_mv AT mullerfabian synergisticimmunotoxinpaclitaxelcombinationagainstlymphoma